To further investigate the role of RUNX3 in GC, we performed IHC analysis which identified marked RUNX3 expression in the peritumoral inflammatory infiltrate, but almost no expression in tumoral or normal adjacent mucosa, in over 90% of the samples analyzed. This evidence concerns the gene RUNX3 and gastric cancer.